NCT03164291View on ClinicalTrials.gov

Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 30, 1984

Primary Completion Date

September 30, 2006

Study Completion Date

May 18, 2017

Conditions
Nontuberculous Mycobacterial Infections
Interventions
DRUG

Rifabutin

Rifabutin dosage dependent on clinical factors such as age, weight, and patient-specific health status

Trial Locations (1)

75708

The University of Texas Health Science Center at Tyler, Tyler

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

The University of Texas Health Science Center at Tyler

OTHER